Intranuclear rod myopathy

What it is, symptoms and effects

From: MedlinePlus Genetics, National Library of Medicine

Intranuclear rod myopathy is a muscle disorder (myopathy) that causes severe weakness that is noticeable in infancy. This condition primarily affects the muscles used for movement (skeletal muscles) and breathing (respiratory muscles).

In infants with intranuclear rod myopathy, weak muscle tone (hypotonia) throughout the body can impair movement before and after birth. Infants with hypotonia can develop other problems in their bones and joints, including:

Other signs and symptoms of intranuclear rod myopathy that are apparent in infancy include:

Respiratory muscle weakness in infants with intranuclear rod myopathy can cause frequent respiratory infections and shallow breathing (hypoventilation). Hypoventilation, especially during sleep, can result in a shortage of oxygen and a buildup of carbon dioxide in the blood. In many cases, affected individuals do not have the muscle strength to breathe regularly on their own and must be supported with a machine to help them get enough oxygen (mechanical ventilation).

Because of these respiratory problems, most individuals with intranuclear rod myopathy do not survive past infancy. Those who survive often develop motor skills such as sitting, crawling, standing, and walking, more slowly than other children.

The name of the condition, intranuclear rod myopathy, comes from the abnormal rod-shaped structures that can be seen in the nucleus of muscle cells when muscle tissue is viewed under a microscope.

Causes and biological mechanisms

From: MedlinePlus Genetics, National Library of Medicine

Genetic changes that cause disease are called pathogenic variants. Pathogenic variants in the ACTA1 gene cause intranuclear rod myopathy. The ACTA1 gene provides instructions for making skeletal alpha (α)-actin, which is part of the actin protein family. Actin proteins are important for cell movement and the tensing of muscle fibers (muscle contraction). Muscle fibers are primarily composed of thin filaments that are made up of actin molecules and thick filaments that are made up of another protein called myosin. The thin and thick filaments overlap each other and undergo cycles of attachment and release that allow the thin filaments to slide past the thick filaments, which shortens the muscle fiber and causes the muscle to contract.

The pathogenic variants in the ACTA1 gene that cause intranuclear rod myopathy allow rods of skeletal α-actin to accumulate in the nucleus of muscle cells. Normally, actin is found in the fluid surrounding the nucleus (the cytoplasm); only small amounts are in the nucleus itself.

Researchers suggest that the ACTA1 gene variants that cause intranuclear rod myopathy interfere with the normal transport of actin out of the nucleus and into the cytoplasm, resulting in the accumulation of actin in the nucleus and the formation of intranuclear rods. The buildup of these rods can interfere with the normal functioning of the nucleus, such as directing cell growth and producing proteins from genes. Abnormal accumulation of actin in the nucleus of muscle cells and a corresponding reduction of available actin in muscle fibers impairs muscle contraction and leads to the muscle weakness seen in people with intranuclear rod myopathy.

Some people with intranuclear rod myopathy do not have an identified pathogenic variant in the ACTA1 gene. The cause of the disorder in these individuals is unknown.

Intranuclear rod myopathy is one of several muscle disorders caused by pathogenic variants in the ACTA1 gene. Some researchers consider these disorders to be a single disorder with a spectrum of overlapping signs and symptoms and group them together under the umbrella term alpha-actinopathy.

Inheritance and family implications

From: MedlinePlus Genetics, National Library of Medicine

Intranuclear rod myopathy is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Most cases of this condition result from new (de novo) variants in the gene that occur during the formation of reproductive cells (eggs or sperm) in an affected individual's parent or in early embryonic development. These affected individuals have no history of the disorder in their family.

How common is it?

From: MedlinePlus Genetics, National Library of Medicine

Intranuclear rod myopathy is a rare disorder that has been identified in only a small number of individuals. Its exact prevalence is unknown.

Which doctor should you see?

The suggested department for discussing Intranuclear rod myopathy is Clinical Genetics, with a clinical geneticist as the relevant type of clinician. Paediatrician (children) or physician (adults), with clinical geneticist referral.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

• Does the exact genetic or chromosome finding explain the observed features?
• Would a genetic counsellor help the family understand the result?
• Which organ-specific assessments are appropriate for this particular diagnosis?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Intranuclear rod myopathy. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.